Bolognesi D P
Duke Center for AIDS Research, Duke University Medical Center, Durham, NC 27710.
Semin Immunol. 1993 Jun;5(3):203-14. doi: 10.1006/smim.1993.1024.
HIV infection is accompanied by a vigorous immune response to the virus consisting of humoral and cellular elements that effectively neutralize virus infectivity and lyse infected cells when analyzed in cell culture models. However, this immune response shows no evidence of being able to eliminate the infection. The inability to clear this infection places HIV in a category of viruses for which vaccines have yet to be successfully developed. Indeed, effective vaccines have emerged only for viruses where natural immunity is part of the pathogenic process; it is such immunity that became the guiding principle for the development of the respective vaccines. It follows that the unique features of HIV infection and pathogenesis are issues to consider carefully in formulating vaccine strategies, particularly those that relate to its susceptibility to immune attack on the one hand, and its mechanisms of immune escape on the other.
HIV感染伴随着对该病毒的强烈免疫反应,这种反应由体液和细胞成分组成,在细胞培养模型中分析时,这些成分能有效中和病毒感染性并裂解被感染细胞。然而,这种免疫反应并无证据表明能够消除感染。无法清除这种感染使得HIV属于尚未成功研发出疫苗的一类病毒。事实上,仅针对自然免疫是致病过程一部分的病毒才出现了有效疫苗;正是这种免疫成为了相应疫苗研发的指导原则。因此,在制定疫苗策略时,尤其是那些一方面涉及HIV对免疫攻击的敏感性、另一方面涉及其免疫逃逸机制的策略时,HIV感染和发病机制的独特特征是需要仔细考虑的问题。